Cancer Nanotechnology Training Program

 描述（由申请人提供）：随着用于癌症检测、诊断和治疗的许多不同的基于纳米技术的平台的快速发展，对MD和PhD级科学家的巨大需求不仅能够产生额外的癌症纳米材料，而且能够优化其生物学特性，并评估其安全性和临床疗效。西北大学（NU）提出的新T32癌症纳米技术培训计划的目标是毕业学员谁是精通纳米技术的原理和工具，谁有癌症生物学和临床肿瘤学的良好工作知识，谁可以应用他们的纳米技术技能和知识转化研究影响癌症患者。为了实现这些目标，培训计划将提供研究培训，跨越癌症纳米技术主题的连续统一体，广泛的教育课程，赋予互补的知识基础，以及多方面的职业发展计划，为学员的学术生涯以及其他研究相关的职业生涯做好准备。将建立多种机制来评估学员、导师和整个计划的表现。学员将有机会获得广泛的资源和计划的支持，由罗伯特H。Lurie综合癌症中心，该中心将管理培训项目，所有18名培训项目导师都隶属于该中心。培训将在充满纳米技术资源的环境中进行，包括NU国际纳米技术研究所，医学生物纳米技术研究所和NU癌症纳米技术卓越中心。该项目的18位导师中的大多数都与一个或多个纳米技术研究所有联系。该计划将招收MD和Ph.D.的混合。我们要求在五年内每年为四名受训人员提供支助。

 DESCRIPTION (provided by applicant): With the rapid development of many different nanotechnology-based platforms for cancer detection, diagnosis and therapy, there is a tremendous need for MD and PhD-level scientists who are capable not only of generating additional cancer nanomaterials but also of optimizing their biological properties, and evaluating their safety and clinical efficacy. The goal of the proposed new T32 Cancer Nanotechnology Training Program at Northwestern University (NU) is to graduate trainees who are well-versed in the principles and tools of nanotechnology, who have a good working knowledge of cancer biology and clinical oncology, and who can apply their nanotechnology skills and knowledge to translational research that impacts cancer patients. To accomplish these goals, the training program will provide research training that spans a continuum of cancer nanotechnology topics, an extensive educational curriculum that confers a complementary knowledge base, and a multifaceted career development program that prepares trainees for academic careers as well as for other research-related careers. Multiple mechanisms will be in place to evaluate the performance of the trainees, mentors, and the overall program. Trainees will have access to a wide array of resources and programs supported by the Robert H. Lurie Comprehensive Cancer Center, which will administer the training program and with which all 18 of the training program preceptors are affiliated. Training will occur within a milieu replete with nanotechnology resources, including those of NU's International Institute for Nanotechnology, the Institute for BioNanotechnology in Medicine, and the NU Center for Cancer Nanotechnology Excellence. Most of the program's 18 preceptors have ties to one or more of these nanotechnology institutes. The program will enroll a mix of MD and Ph.D. trainees, and we are requesting support for four trainees per year for five years.